The End Prescription Drug Ads Now Act aims to eliminate direct-to-consumer drug advertising across all media platforms, prioritizing patient health.

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a seven-year test, which would tie US drug prices to the lowest prices paid by ...

Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...

What an exciting time to be alive, especially for those younger than myself. An insightful article in Fortune, ...

Senator Bernie Sanders is leading a new bill to address a key priority of Robert F. Kennedy Jr., who serves as President ...

Adopting most-favored-nation pricing could save hundreds of billions of dollars along the way to holding PBMs more ...

A recent poll released by the Pharmaceutical Reform Alliance (PRA) found that a majority of Americans approve of President ...

From extensive regulatory reforms to economic pressures reshaping pharmacy access and pricing, these are some of the most ...

President Donald J. Trump has signaled that lowering the costs of prescription drugs will be a priority for his second term.

The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still ...

What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

Medpace has a strong financial position with high profit margins and low debt. Click here to read more about MEDP stock.